Peptide · Body Protection Compound File No. AR-003 · BPC-157 · Pentadecapeptide

BPC-157

The internet's favorite healing peptide — and the widest gap between hype and human evidence in the archive.

Preclinical-Dominant Extreme Hype Gap Banned in Pro Sport · Not FDA-Approved Reviewed Jul 2026

The 30-second version

BPC-157 is one of the most-studied peptides in animals — and one of the least-studied in humans. There are 100+ animal studies, but fewer than 30 people have ever been in a published BPC-157 study, and not one was a proper controlled trial. So when TikTok says it "heals everything," the honest answer is: it's promising in rats, largely unproven in people.

100+

Animal / lab studies

<30

Humans ever studied

Controlled human trials

Does it heal injuries in humans?

Not proven — no controlled trials

Is the animal research real?

Yes — extensive and decades deep

Is it FDA-approved?

No — and banned in pro sport

Is it known to be safe long-term?

Unknown — too few humans studied

Below: the full picture

The Deep Dive

What the research actually shows

Everything below is drawn from the published record — animal studies, the handful of human reports, systematic reviews, and regulators. Human evidence is kept separate from animal evidence throughout.

What it is

BPC-157 ("Body Protection Compound-157") is a synthetic 15-amino-acid peptide based on a sequence found in human gastric juice. In animal studies it's been linked to tissue repair through several plausible mechanisms — promoting new blood-vessel growth (VEGF), modulating nitric oxide, and reducing inflammatory signals.

It is not FDA-approved for any use, sits on the FDA's Category 2 list (can't currently be legally compounded due to insufficient safety data), and was banned by the NFL, UFC, NCAA and WADA around 2022. In April 2026 the UK's medicines regulator (MHRA) opened an investigation into peptide clinics marketing it, naming BPC-157 first.

Evidence, claim by claim

A single score for "BPC-157" would hide the whole story. What matters is the specific claim — because the evidence is completely different for each one. Here's how the biggest claims actually hold up.

Tendon & muscle healingInjected / local · the headline claim

No human evidence

The claim that made BPC-157 famous. It rests almost entirely on animal models — a 2025 systematic review in the American Journal of Sports Medicine screened 544 articles and found only one human clinical study. The tendon-healing story is real in rats; in people it is essentially untested.

Human None controlledAnimal Strong, consistentConfidence Very low

Gut & IBD supportOral / systemic

Preclinical + early signals

This is arguably BPC-157's strongest research area — its origin is a gut peptide, it's unusually stable in stomach acid, and preclinical IBD/ulcer models are consistent. But the human side is still small case reports and observational use, not controlled trials.

Human Very limitedAnimal StrongConfidence Low

Knee & joint painIntra-articular injection

Small uncontrolled human reports

A 2021 case series of ~16 patients reported subjective pain improvement after injection. Genuinely human data — but tiny, uncontrolled, and without a placebo group, so it can't separate real effect from natural recovery or expectation.

Human ~16, no controlAnimal SupportiveConfidence Low

"Heals everything" / systemic regenerationAny route

Not supported

The blanket internet claim. No human evidence supports BPC-157 as a general-purpose healing agent, and framing it that way ignores that every tissue and route needs its own testing. This is where the hype most exceeds the science.

Human NoneAnimal Varies by tissueConfidence Very low

The internet vs. the evidence

What you'll hear online

"BPC-157 heals tendons, joints, gut, and nerves. It's a proven recovery miracle — the body's own repair peptide. Everyone in the gym is on it."

What the evidence shows

Decades of animal research make it scientifically interesting, but fewer than 30 humans have ever been studied and no controlled trial has been completed. "Proven" is the wrong word — "promising but largely untested in people" is accurate.

What was actually studied

Why we show this: understanding what researchers actually used — and how little has been tested in people — is part of being informed. This is a record of what published studies did, not a protocol, recommendation, or instruction to use anything. Aphrodite provides no dosing guidance.

Study & populationAmount administered in studyObserved outcomes

IV safety pilotLee & Burgess, 2025 · n=2 adults

10 mg & 20 mg IV, single infusions

No adverse effects on cardiac, liver, kidney, thyroid or glucose markers; plasma cleared within 24h. Too small to judge efficacy.

Knee pain case seriesLee & Padgett, 2021 · n≈16

2–4 mcg intra-articular, single injection

Majority reported subjective pain relief lasting 6+ months. No control group; can't rule out natural recovery.

Interstitial cystitis pilotLee et al., 2024 · n≈12

Single intravesical (bladder) dose

High reported symptom resolution in a small, uncontrolled sample. Preliminary only.

Note: all three published human studies share the same lead investigator, and none used a placebo control. Widely-shared "protocols" online are extrapolated from rodent studies and community practice — not from human dose-finding trials, which don't yet exist.

What people report — checked against the evidence

Anecdotes aren't evidence, but they're often what sends someone searching in the first place. So here's the honest version: the things people commonly say online about BPC-157, each held up against what the research actually shows. Reported experience is a starting question, not an answer.

What people say

"It healed my tendon injury in weeks when nothing else worked."

Not supported

What the evidence showsThis is the most common claim — and the least supported in humans. Tendon and soft-tissue healing has never been demonstrated in a controlled human trial. Recovery stories can't separate the compound from natural healing, rest, physical therapy, or the strong placebo effect that accompanies any self-directed treatment. The animal data is real; the human "it worked for me" is not evidence it did.

What people say

"It fixed my gut issues and calmed my stomach down."

Biologically plausible, unproven

What the evidence showsOf all the claims, this one has the most going for it — BPC-157 originates from a gut peptide, survives stomach acid, and has consistent preclinical gut-protective data. But "consistent in animals and plausible" still isn't the same as "proven in people." Human evidence here is small case reports, not controlled trials, so this stays a promising hypothesis rather than an established effect.

What people say

"My knee pain went away for months after a couple injections."

Some human signal, uncontrolled

What the evidence showsThis one actually has a sliver of human data — a 2021 case series of ~16 patients reported lasting pain relief after intra-articular injection. That's real, and worth noting. But with no placebo group and a tiny sample, it can't rule out natural recovery or expectation. It's the strongest "it worked" story with the weakest proof structure — genuine signal, not yet genuine evidence.

What people say

"It's completely safe — it's just a peptide your body already makes."

Misleading

What the evidence showsTwo problems. First, "your body makes it" overstates the case — BPC-157 is a synthetic fragment based on a gastric sequence, not something your body produces as-is. Second, "completely safe" can't be claimed when fewer than 30 humans have ever been formally studied, there's no long-term data, and the blood-vessel-growth pathway raises an unresolved tumor-risk question. Reassuring anecdotes can't substitute for safety data that doesn't exist yet.

◆ Why we include this

We report what people say to inform, never to encourage. Self-reported benefit is exactly what controlled trials exist to confirm or overturn — and for BPC-157, those trials mostly don't exist yet. If your decision is riding on anecdotes, that itself is the most important thing to know.

Safety, honestly

Short-term

Across the ~30 humans ever studied, no serious adverse events were reported, and animal studies found no lethal or toxic dose. That's mildly reassuring — but the sample is far too small for real safety conclusions.

The open question

The same blood-vessel-growth pathway (angiogenesis) that could aid healing can also, in theory, support tumor growth. Reviewers flag this as unresolved, especially for anyone with current or prior cancer. No long-term human safety data exists.

Product risk

Because it's sold through unregulated channels, what's in a vial labeled "BPC-157" isn't verified — purity, dose, and even identity vary. This is a real-world risk the research doesn't address.

Reported for education

This is a summary of the published record, not medical advice or a suggestion to use anything. Decisions about investigational compounds belong with a qualified clinician.

Sources

01Vasireddi N, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. American Journal of Sports Medicine / HSS J, 2025. Link
02Lee E, Burgess A. Safety of Intravenous Infusion of BPC-157 in Humans: A Pilot Study. Alternative Therapies in Health and Medicine, 2025.
03Oral Peptide BPC-157 — GI systematic review (36 studies, 1993–2025). American Journal of Gastroenterology, 2025. Link
04Multifunctionality and Possible Medical Application of the BPC-157 Peptide — Literature and Patent Review. NCBI/PMC, 2025. Link
05UK MHRA investigation into peptide-clinic marketing, April 2026 (BPC-157 named).

Written byAphrodite Research editorial

Evidence reviewedJuly 2026

Databases searchedPubMed · NCBI · systematic reviews

Conflicts of interestNone · no compounds sold